The News-Times on MSN
95 people with cancer sue CT's Boehringer Ingelheim over recalled drug Zantac
“[Boehringer Ingelheim] had little incentive to investigate the dangers in a product that was producing over $1 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results